Evidence map›Paper›PMID 39190663›Full record

ArticlePLOS global public health2024

Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco.

Safae Belayachi, Fatima Zahra Boukhari, Firdaous Essayagh, Othmane Terkiba, Alban Zohoun, Meriem Essayagh, Touria Essayagh, Sanah Essayagh

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Safae BelayachiLaboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco.
Fatima Zahra BoukhariLaboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco.
Firdaous EssayaghLaboratoire Droit Privé et Enjeux de Développement, Faculté des Sciences Juridiques, Économiques et Sociales, Université Sidi Mohamed Ben Abdellah, Fès, Morocco.
Othmane TerkibaLaboratoire Sciences et Technologies de la Santé, Institut Supérieur des Sciences de la Santé, Hassan First University of Settat, Settat, Morocco.
Alban ZohounUnité D'enseignement et de Recherche en Hématologie, Faculté des Sciences de la Santé, Université d'Abomey-Calavi, Cotonou, Bénin.
Meriem EssayaghOffice National de Sécurité Sanitaire des Produits Alimentaires, Oriental, Morocco.
Touria EssayaghLaboratoire Sciences et Technologies de la Santé, Institut Supérieur des Sciences de la Santé, Hassan First University of Settat, Settat, Morocco.ORCID https://orcid.org/0000-0002-6906-2512
Sanah EssayaghLaboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-adherence to hypertensive drugs is a barrier to controlling blood pressure and decreases hypertensive patients' quality of life. The aim of this study was to determine the prevalence of non-adherence to hypertensive drugs among hypertensive patients treated at Marrakech's primary health care facilities. A cross-sectional survey of 922 hypertensive patients treated at Marrakech's primary health care facilities for arterial hypertension was conducted between 2021 and 2022. For collecting data, two questionnaires were employed. One was administered during an interview to patients and focused on socio-demographic, behavioral, and clinical variables, as well as hypertensive treatment characteristics and the care-patient-physician triad. The physician self-administered the second questionnaire to assess therapeutic inertia. Non-adherence risk factors were identified using multivariate logistic regression. A total of 760 participants did not adhere to the hypertensive drugs, with a prevalence of 82.4%. The average age was 62.8±9.8 years, and 600 (78.9%) of the participants were female. Moderate stress, unsatisfactory family support, uncontrolled hypertension, the presence of depressive symptoms, an insufficient patient-physician interaction, and inadequate medical management of cardiovascular risk factors were associated with drug non-adherence. Non-adherence to hypertensive treatment is common in Marrakech. Regular therapeutic education classes and support group meetings must be scheduled. A performance-based remuneration system to incentivize health-care workers should be investigated.

Identifiers

PMID39190663
PMCPMC11349104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.